Comera Life Sciences Q3 EPS $(0.10) Up From $(0.20) YoY, Sales $136.31K Down From $234.92K YoY
Portfolio Pulse from Benzinga Newsdesk
Comera Life Sciences (NASDAQ:CMRA) reported Q3 losses of $(0.10) per share, a 50% improvement from $(0.20) per share YoY. However, sales decreased by 41.98% to $136.31K from $234.92K YoY.
November 09, 2023 | 1:19 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Comera Life Sciences reported improved EPS losses but a significant decrease in sales YoY.
While the company has managed to reduce its losses per share, the significant decrease in sales could be a concern for investors, potentially leading to a negative impact on the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100